Platelet-targeted gene therapy with human factor VIII establishes haemostasis in dogs with haemophilia A
Open accessThe DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
It is essential to improve therapies for controlling excessive bleeding in patients with haemorrhagic disorders. As activated blood platelets mediate the primary response to vascular injury, we hypothesize that storage of coagulation Factor VIII within platelets may provide a locally inducible treatment to maintain haemostasis for haemophilia A. Here we show that haematopoietic stem cell gene therapy can prevent the occurrence of severe bleeding episodes in dogs with haemophilia A for at least 2.5 years after transplantation. We employ a clinically relevant strategy based on a lentiviral vector encoding the ITGA2B gene promoter, which drives platelet-specific expression of human FVIII permitting storage and release of FVIII from activated platelets. One animal receives a hybrid molecule of FVIII fused to the von Willebrand Factor propeptide-D2 domain that traffics FVIII more effectively into α-granules. The absence of inhibitory antibodies to platelet-derived FVIII indicates that this approach may have benefit in patients who reject FVIII replacement therapies. Thus, platelet FVIII may provide effective long-term control of bleeding in patients with haemophilia A.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia B
Nathwani, A. C., Tuddenham, E. G. D., Rangarajan, S., Rosales, C., McIntosh, J., Linch, D. C., Chowdary, P., Riddell, A., Pie, A. J., Harrington, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1108046 · Cited by 1,864
Langdell, R. D., Wagner, R. H., & Brinkhous, K. M. (1953) · PubMed · Cited by 852
Sanders, J., Hawley, J., Levy, W., Gooley, T., Buckner, C., Deeg, H., Doney, K., Storb, R., Sullivan, K., Witherspoon, R., et al. (1996) · Blood · doi:10.1182/blood.v87.7.3045.bloodjournal8773045 · Cited by 722
Wiznerowicz, M., & Trono, D. (2003) · Journal of Virology · doi:10.1128/jvi.77.16.8957-8951.2003 · Cited by 701
Kitazawa, T., Igawa, T., Sampei, Z., Muto, A., Kojima, T., Soeda, T., Yoshihashi, K., Okuyama-Nishida, Y., Saito, H., Tsunoda, H., et al. (2012) · Nature Medicine · doi:10.1038/nm.2942 · Cited by 507
Megakaryocytic and erythrocytic lineages share specific transcription factors
Romeo, P.-H., Prandini, M.-H., Joulin, V., Mignotte, V., Prenant, M., Vainchenker, W., Marguerie, G., & Uzan, G. (1990) · Nature · doi:10.1038/344447a0 · Cited by 418
Specific roles for platelet surface glycoproteins in platelet function
NURDEN, A. T., & CAEN, J. P. (1975) · Nature · doi:10.1038/255720a0 · Cited by 405
Self-citationSynthesis, processing, and secretion of recombinant human factor VIII expressed in mammalian cells.
Kaufman, R. J., Wasley, L. C., & Dorner, A. J. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68793-9 · Cited by 380
Berntorp, E., & Shapiro, A. D. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61139-2 · Cited by 335
Beyond Clotting: The Powers of Platelets
Leslie, M. (2010) · Science · doi:10.1126/science.328.5978.562 · Cited by 332
Cited by
Items 101–118 of 118
Therapeutic induction of tolerance to reverse allergen-induced airway inflammation
Kouba, J. A. (2015) · The University of Queensland · doi:10.14264/uql.2015.919
“…success in tolerance induction and control of the disease in a non obese diabetes (NOD) mouse model (Steptoe et al. 2003), in mouse models of allergy (Baranyi et al. 2012, Gattringer et al. 2013), and in animal disease models of haemophilia (Chang et al. 2008, Du et al. 2013, Shi et al. 2014).”
Treating Hemophilia by Gene Therapy
Porada, C. D., Ignacio, G., Atala, A., & Almeida-Porada, G. D. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800548-4.00012-7
Plasma Components as Targets of Damage
Finn, J. A., & Vyas, G. N. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-386456-7.06211-0
Gene Therapy for Bleeding Disorders
Monahan, P. E., & Abajas, Y. L. (2016) · Springer eBooks · doi:10.1007/978-3-319-30352-9_29
Strategies for the Gene Modification of Megakaryopoiesis and Platelets
Latorre-Rey, L. J., & Modlich, U. (2016) · Springer eBooks · doi:10.1007/978-3-319-39562-3_20
Construção e análise funcional de vetores lentivirais de interesse biotecnológico
Vedoveli, N. C. P. S. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2016.tde-26082016-152814 · Cited by 1
Diagnosis of haemophilia A in a Miniature Longhaired Dachshund
Gordon, G., & Kilpatrick, S. (2017) · The Veterinary Nurse · doi:10.12968/vetn.2017.8.8.463 · Cited by 1
Novakowski, S. K., & Kastrup, C. J. (2019) · Health Science Inquiry · doi:10.29173/hsi7
“[3] Du LM, Nurden P, Nurden AT, Nichols TC, Bellinger DA, Jensen ES, et al. Platelet-targeted gene therapy with human factor VIII establishes haemostasis in dogs with haemophilia A. Nature communications.”
Background[Advances of hemophilia A treatment].
Zhang, W., & Mao, J. H. (2018) · PubMed Central · doi:10.3760/cma.j.issn.0253-2727.2018.01.023
“[35] Du LM, Nurden P, Nurden AT, et al.”
BackgroundShi, Q., & Montgomery, R. R. (2017) · Springer eBooks · doi:10.1007/978-3-319-47462-5_97
Self-citation(2013) · Japanese Journal of Thrombosis and Hemostasis · doi:10.2491/jjsth.25.110
Gene Therapy in Haemophilia: Updates from Clinical Trials and Insights to Future Technologies
Carter, S. (2022) · EMJ Cardiology · doi:10.33590/emjcardiol/10136425
Hematopoietic Stem Cell-Based Platelet-Targeted Gene Therapy for Hemophilia
Shi, Q. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15717-2.00125-6
Self-citationSamelson‐Jones, B. J. (2025) · Research and Practice in Thrombosis and Haemostasis · doi:10.1016/j.rpth.2025.102716
Platelet-Mediated Gene and Cell Therapy
Miao, C. H. (2025) · Springer eBooks · doi:10.1007/978-3-031-96360-5_18
Nurden, A. T., & Nurden, P. (2025) · Springer eBooks · doi:10.1007/978-3-031-96340-7_1
Self-citationGong, J., Yang, R., Zhou, M., & Chang, L.-J. (2023) · Figshare · doi:10.6084/m9.figshare.23504967
Gong, J., Yang, R., Zhou, M., & Chang, L.-J. (2023) · Figshare · doi:10.6084/m9.figshare.23504970
Metadata
- Authors
- Du, L. M., Nurden, P., Nurden, A. T., Nichols, T. C., Bellinger, D. A., Jensen, E. S., Haberichter, S. L., Merricks, E., Raymer, R. A., Fang, J., Koukouritaki, S. B., Jacobi, P. M., Hawkins, T. B., Cornetta, K., Shi, Q., & Wilcox, D. A.
- Affiliations
- Children's Hospital of Wisconsin (US)
- Electrophysiology and Heart Modeling Institute (FR)
- University of North Carolina at Chapel Hill (US)
- Versiti Blood Center of Wisconsin (US)
- Indiana University Indianapolis (US)
- Corresponding author
- Wilcox, David A.
- ORCID
- Venue
- Nature Communications
- Published
- 2013-11-19
- Volume
- 4
- Issue
- 1
- Pages
- 2773-2773
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC3868233
- OpenAlex
- W2039928766
- Cited by
- 119
- References
- 59
- Citations by year
- 2025: 5 · 2024: 4 · 2023: 11 · 2022: 11 · 2021: 9 · 2020: 9 · 2019: 6 · 2018: 9 · 2017: 7 · 2016: 14 · 2015: 21 · 2014: 11 · 2013: 2
- FWCI
- 11.48
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Nature Communications (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- IUScholarWorks (Indiana University) (submittedVersion, cc-by)
- UNC Libraries
- Funders
- American Heart Association
- Medical College of Wisconsin
- Children’s Hospital of Wisconsin Research Institute
- Children's Hospital Foundation
- Agence Nationale de la Recherche (ANR-08-GENO-028-03)
- Institut National de la Santé et de la Recherche Médicale (ANR-08-GENO-028-03)
- National Institutes of Health (HL-68138, HL63098)
- University of North Carolina at Chapel Hill
- National Heart, Lung, and Blood Institute (HL-102035, P40HL116242, HL 68138, R24HL063098, R01HL068138, HL-63 098, R01HL102035)
- Topics
- Health Sciences › Medicine › Hematology › Hemophilia Treatment and Research
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Keywords
- hemophilia A, factor VIII, hemostasis, lentiviral vectors, platelet alpha-granules, factor VIII inhibitors, dogs, hemorrhage control
- MeSH terms
- Animals, Blood Platelets, Dog Diseases, Dogs, Factor VIII, Gene Expression Regulation, Hemophilia A, Hemostasis, Humans, Genetic Therapy, Integrin alpha2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.